Latest filing published 18 May 2023 for Prostatype Genomics AB, €12k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
JDS Invest AB JDS Invest AB: trading record in brief
All filings by JDS Invest AB JDS Invest AB on record concern Prostatype Genomics AB. In total, 2 filings cover trades dated from 11 May 2023 to 16 May 2023.
The open-market record is one-sided, with 2 purchases worth €156k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 18 May 2023: an open-market purchase of €12k, in Prostatype Genomics AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to JDS Invest AB JDS Invest AB
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 540,123 shares@ SEK 0.257.7% of flowBTA (betald tecknad aktie)ISIN SE0020179430FI:csv-9c7e8aa863cf1173b567Canonical exit: 14 Aug 2023 (T+90)
- 6,487,896 shares@ SEK 0.2592.3% of flowBTA (betald tecknad aktie)ISIN SE0020179430FI:csv-189b18b786dab28f75b8Canonical exit: 9 Aug 2023 (T+90)
2 of 2 declarations